Dual therapy with an angiotensin receptor blocker and a JAK1/2 inhibitor attenuates dialysate-induced angiogenesis and preserves peritoneal membrane structure and function in an experimental CKD rat model
Related Posts
Gorsi U, Kim N, Sukhija R, Kumar J, Nabavizadeh P. Critical Rheumatic Mitral Stenosis Unmasked During Pregnancy Complicated by Preeclampsia With Severe Features and Managed[...]
Gu Y, Gebremariam T, Ibrahim BA, Harb K, Chan A, Ibrahim AS. Transferrin Enhances Antifungal Therapy and Improves Survival in Experimental Mucormycosis. J Fungi (Basel).[...]
Moy ML, Casaburi R, Nici L. Initial Results Do Not Support That Fully Virtual Pulmonary Rehabilitation Widens Reach to Underserved Patients With COPD. Chronic Obstr[...]